APA (7th ed.) Citation

Ni, S., Ma, S., Yu, Y., Yu, Z., Zhu, Y., Sun, X., . . . Fan, J. (2024). Pharmacokinetics, Mass Balance, and Biotransformation of [14C]tinengotinib, A Novel Multi-target Kinase Inhibitor, in Healthy Subjects. Drugs in R&D, 24(3), 465-476. https://doi.org/10.1007/s40268-024-00486-2

Chicago Style (17th ed.) Citation

Ni, Shumao, et al. "Pharmacokinetics, Mass Balance, and Biotransformation of [14C]tinengotinib, A Novel Multi-target Kinase Inhibitor, in Healthy Subjects." Drugs in R&D 24, no. 3 (2024): 465-476. https://doi.org/10.1007/s40268-024-00486-2.

MLA (9th ed.) Citation

Ni, Shumao, et al. "Pharmacokinetics, Mass Balance, and Biotransformation of [14C]tinengotinib, A Novel Multi-target Kinase Inhibitor, in Healthy Subjects." Drugs in R&D, vol. 24, no. 3, 2024, pp. 465-476, https://doi.org/10.1007/s40268-024-00486-2.